AGAPE ATP CORPORATION Marketable Securities, Unrealized Gain (Loss)
AGAPE ATP CORPORATION (ATPC) reported Marketable Securities, Unrealized Gain (Loss) of -$15.39 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-14
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$15.39K, a 298.59% decline year-over-year.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was $12.23K.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $5.79K, a 256.40% increase year-over-year.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was -$3.49K.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for fiscal 2025 was $8.95K.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for fiscal 2024 was -$5.02K, a 243.66% decline from fiscal 2023.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for fiscal 2023 was $3.49K.
- AGAPE ATP CORPORATION marketable securities, unrealized gain (loss) for fiscal 2022 was -$73.52K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.39K 10-Q · filed 2026-08-14 | -$3.15K 10-Q · filed 2026-08-14 | $2.63K derived: sum of 3 quarters · filed 2026-08-14 | -$854.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $12.23K 10-Q · filed 2026-05-15 | $18.02K derived: sum of 2 quarters · filed 2026-05-15 | $14.53K derived: sum of 3 quarters · filed 2026-05-15 | $22.28K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $5.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $2.30K derived: sum of 2 quarters · filed 2026-04-13 | $10.05K derived: sum of 3 quarters · filed 2026-08-14 | $8.95K 10-K · filed 2026-04-13 |
| 2025-09-30 | -$3.49K 10-Q · filed 2025-11-13 | $4.26K derived: sum of 2 quarters · filed 2026-08-14 | $3.17K 10-Q · filed 2025-11-13 | $4.79K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $7.75K 10-Q · filed 2026-08-14 | $6.65K 10-Q · filed 2026-08-14 | $8.28K derived: sum of 3 quarters · filed 2026-08-14 | $7.10K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.10K 10-Q · filed 2026-05-15 | $528.00 derived: sum of 2 quarters · filed 2026-05-15 | -$648.00 derived: sum of 3 quarters · filed 2026-05-15 | -$7.29K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $448.00 derived: sum of 2 quarters · filed 2026-04-13 | -$6.19K derived: sum of 3 quarters · filed 2026-04-13 | -$5.02K 10-K · filed 2026-04-13 |
| 2024-09-30 | -$1.18K 10-Q · filed 2025-11-13 | -$7.82K derived: sum of 2 quarters · filed 2025-11-13 | -$6.64K 10-Q · filed 2025-11-13 | -$7.99K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$6.64K 10-Q · filed 2025-08-13 | -$5.47K 10-Q · filed 2025-08-13 | -$6.81K derived: sum of 3 quarters · filed 2025-08-13 | -$10.68K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.17K 10-Q · filed 2025-05-15 | -$172.00 derived: sum of 2 quarters · filed 2025-05-15 | -$4.04K derived: sum of 3 quarters · filed 2025-05-15 | -$254.00 derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$1.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$5.22K derived: sum of 2 quarters · filed 2025-03-31 | -$1.43K derived: sum of 3 quarters · filed 2025-03-31 | $3.49K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$3.87K 10-Q · filed 2024-11-14 | -$82.00 derived: sum of 2 quarters · filed 2024-11-14 | $4.84K 10-Q · filed 2024-11-14 | -$4.40K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $3.79K 10-Q · filed 2024-08-14 | $8.71K 10-Q · filed 2024-08-14 | -$525.00 derived: sum of 3 quarters · filed 2024-08-14 | -$11.92K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $4.92K 10-Q · filed 2024-05-14 | -$4.32K derived: sum of 2 quarters · filed 2024-05-14 | -$15.71K derived: sum of 3 quarters · filed 2024-05-14 | -$50.93K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$9.23K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$20.63K derived: sum of 2 quarters · filed 2024-04-01 | -$55.85K derived: sum of 3 quarters · filed 2024-04-01 | -$73.52K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$11.39K 10-Q · filed 2023-11-14 | -$46.61K derived: sum of 2 quarters · filed 2023-11-14 | -$64.28K 10-Q · filed 2023-11-14 | -$194.62K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$35.22K 10-Q · filed 2023-08-14 | -$52.89K 10-Q · filed 2023-08-14 | -$183.22K derived: sum of 3 quarters · filed 2023-08-14 | -$392.39K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$17.67K 10-Q · filed 2023-05-15 | -$148.00K derived: sum of 2 quarters · filed 2023-05-15 | -$357.17K derived: sum of 3 quarters · filed 2023-05-15 | -$598.20K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$130.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$339.50K derived: sum of 2 quarters · filed 2023-03-31 | -$580.53K derived: sum of 3 quarters · filed 2023-03-31 | -$505.23K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$209.17K 10-Q · filed 2022-11-14 | -$450.20K derived: sum of 2 quarters · filed 2022-11-14 | -$374.90K 10-Q · filed 2022-11-14 | -$127.01K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$241.03K 10-Q · filed 2022-08-11 | -$165.73K 10-Q · filed 2022-08-11 | $82.16K derived: sum of 3 quarters · filed 2022-08-11 | $57.74K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $75.30K 10-Q · filed 2022-05-13 | $323.19K derived: sum of 2 quarters · filed 2022-07-05 | $298.77K derived: sum of 3 quarters · filed 2022-07-05 | $443.97K derived: sum of 4 quarters · filed 2022-07-05 |
| 2020-12-31 | $247.89K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $223.47K derived: sum of 2 quarters · filed 2022-07-05 | $368.68K derived: sum of 3 quarters · filed 2022-07-05 | $350.14K 10-K/A · filed 2022-07-05 |
| 2020-09-30 | -$24.42K 10-Q/A · filed 2022-07-05 | $120.78K derived: sum of 2 quarters · filed 2022-07-05 | $102.25K 10-Q/A · filed 2022-07-05 | |
| 2020-06-30 | $145.20K 10-Q · filed 2021-08-13 | $126.67K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$18.54K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$68.39K 10-K · filed 2021-03-31 | -$68.39K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |